http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6461481-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76299e8825a78f19f9b9e61df0737405 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate | 1987-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db3d70fc287df6c3f15c7026668cd213 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8470304220dabb583836d865e1b40f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a54fcd5a59de3fd6cebd04b363b0c7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b36fdcf941836d8573766a9da61b4f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e272e5ce0897ed58ce3bb02fde96d4f9 |
| publicationDate | 1989-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S6461481-A |
| titleOfInvention | Porphyrin derivative |
| abstract | NEW MATERIAL:A compound expressed by the formula [R1 and R2 represent -CH=CH2, -CH2CH3, etc.; R3 represents H, COOH, -COR (R represents OH or residue formed by eliminating H from an amino-acid), etc.; R4 represents OH or R; A represents CH2- or -CO-; dotted line bonded to the gamma-position represents no-binding or single bond; dotted line between the gamma-position and the 8-position represents single bond or double bond] and metal complex thereof (provided that the metal complex is in a porphyrin skeleton, and at least one of R3 and R4 represents group having R which represents tyrosine, fluorine- containing amino acid or iodine-containing amino acid residue). EXAMPLE:2,4-Bis[1-(2-hydroxyethyloxy)ethyl]-Ga-deuteroporphyrinyl dityrosine. USE:A cancer-directing medical preparation used for treatment, diagnosis, marker and misile-targeting therapeia of cancer. PREPARATION:A porphyrin compound corresponding to the formula wherein R is OH is formed and an amino acid residue is introduced thereto. Iodine, as necessary, is bonded. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100484206-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5492924-A |
| priorityDate | 1987-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.